Literature DB >> 28867433

Epidemiology of Back Pain in Young and Middle-Aged Adults: A Longitudinal Population Cohort Survey From Age 27-50 Years.

Felix Angst1, Jules Angst2, Vladeta Ajdacic-Gross2, André Aeschlimann3, Wulf Rössler4.   

Abstract

BACKGROUND: Back pain is extremely common and a huge burden for both individuals and health care services.
OBJECTIVE: The aim was to determine the prevalence and incidence of lumbar and cervical back pain over 23 years and to quantify associations with concomitant disorders.
METHODS: Data on lumbar and cervical back pain, and mental disorders from the Zurich study, collected between 1986 (age men: 27/women: 28 years) and 2008 (age 49/50) were analyzed. Epidemiological parameters were representative rates for the general population. Associations were quantified by odds ratios (ORs).
RESULTS: Of 499 subjects, 68.9% ever experienced lumbar pain and 60.7% ever experienced cervical back pain; the 23-year prevalences were 66.9% and 54.9% and the 23-year incidences 52.3% and 48.9% for lumbar and cervical back pain, respectively. Annual prevalences varied between 28.4% and 47.2% for lumbar and 18.3% and 54.7% for cervical back pain; the corresponding annual incidences varied by 5.8-13.3% (lumbar) and 7.8-12.6% (cervical). Lumbar back pain was significantly associated with cardiovascular disease (OR = 4.58), obesity (OR = 3.99), asthma spectrum (OR = 5.76), tranquillizer dependence (OR = 5.84), and other comorbidities (ORs = 1.47-3.27). Significant associations with cervical back pain were observed for specific phobia (OR = 5.10), panic attacks (OR = 4.79), and other comorbidities (ORs = 1.61-2.62).
CONCLUSIONS: This study contributes to the refinement of epidemiological data on lumbar and cervical back pain. Some associations with treatable disorders were high, which may offer hope for the indirect management of lumbar and cervical back pain.
Copyright © 2017 The Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Associations; Cervical back pain; Comorbidity; Incidence; Lumbar back pain; Prevalence

Mesh:

Substances:

Year:  2017        PMID: 28867433     DOI: 10.1016/j.psym.2017.05.004

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

1.  On-site multi-component intervention to improve productivity and reduce the economic and personal burden of neck pain in Swiss office-workers (NEXpro): protocol for a cluster-randomized controlled trial.

Authors:  Andrea M Aegerter; Manja Deforth; Venerina Johnston; Markus J Ernst; Thomas Volken; Hannu Luomajoki; Beatrice Brunner; Julia Dratva; Gisela Sjøgaard; Achim Elfering; Markus Melloh
Journal:  BMC Musculoskelet Disord       Date:  2020-06-19       Impact factor: 2.362

Review 2.  The association between headache and low back pain: a systematic review.

Authors:  Arani Vivekanantham; Claire Edwin; Tamar Pincus; Manjit Matharu; Helen Parsons; Martin Underwood
Journal:  J Headache Pain       Date:  2019-07-15       Impact factor: 7.277

3.  Sex Differences in Comorbidity Combinations in the Swedish Population.

Authors:  Laura Basso; Benjamin Boecking; Patrick Neff; Petra Brueggemann; Christopher R Cederroth; Matthias Rose; Birgit Mazurek
Journal:  Biomolecules       Date:  2022-07-06

4.  Higher low back and neck pain in final year Swiss health professions' students: worrying susceptibilities identified in a multi-centre comparison to the national population.

Authors:  Rebecca J Crawford; Thomas Volken; René Schaffert; Thomas Bucher
Journal:  BMC Public Health       Date:  2018-10-19       Impact factor: 3.295

5.  Musculoskeletal pain in other body sites is associated with new-onset low back pain: a longitudinal study among survivors of the great East Japan earthquake.

Authors:  Yutaka Yabe; Yoshihiro Hagiwara; Takuya Sekiguchi; Yumi Sugawara; Masahiro Tsuchiya; Shinichirou Yoshida; Yasuhito Sogi; Toshihisa Yano; Takahiro Onoki; Tadahisa Takahashi; Jun Iwatsu; Ichiro Tsuji; Eiji Itoi
Journal:  BMC Musculoskelet Disord       Date:  2020-04-13       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.